Aura Biosciences Inc (AURA)

NASDAQ
20.34
+1.76(+9.47%)
Pre Market
18.85
-1.49(-7.33%)
- Real-time Data
  • Volume:
    221,742
  • Day's Range:
    18.57 - 24.83
  • 52 wk Range:
    11.98 - 26.16
Unusual Pre-Market activity today
1 / 3

AURA Overview

Prev. Close
18.58
Day's Range
18.57-24.83
Revenue
-
Open
18.57
52 wk Range
11.98-26.16
EPS
-2.65
Volume
221,742
Market Cap
595.43M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
110,331
P/E Ratio
-7.18
Beta
-
1-Year Change
-
Shares Outstanding
29,273,647
Next Earnings Date
Nov 24, 2022
What is your sentiment on Aura Biosciences?
or
Market is currently closed. Voting is open during market hours.

Aura Biosciences Inc Company Profile

Aura Biosciences Inc Company Profile

Employees
52

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellSellStrong BuyStrong BuyStrong Buy
SummaryStrong SellNeutralStrong BuyStrong BuyStrong Buy